• February 16, 2024

    Tchaikapharma has received marketing authorization for a new medicinal product:   Telmira 60 mg film-coated tablets Telmira 90 mg film-coated tablets   Telmira contains a medicinal substance called ticagrelor. It belongs to a group of medicines called antithrombotic medicines.   Telmira, given at the same time as acetylsalicylic acid (ASA), is indicated for the prevention […]

  • November 16, 2023

    The latest medicinal product to receive Marketing Authorisation from the Bulgarian Drug Agency is:   Ferbessa 4 mg/5 mg tablets   Ferbessa 8 mg/5 mg tablets   Ferbessa is a combination of the two active substances: perindopril and amlodipine. Perindopril is an angiotensin-converting enzyme inhibitor (ACE inhibitor). Amlodipine is a calcium antagonist that belongs to […]

  • October 2, 2023

    mag. pharma. Silvia Patrikova, Director of ‘Pharmaceutical Care’ and Member of the Board of Directors of Tchaikapharma High Quality Medicines   Nearly two years after the peak of the COVID-19 pandemic, the global pharmaceutical market is suffering from chaos in supply chains and unpredictable dynamics in demand for individual products. It is difficult to guarantee […]

  • July 14, 2023

    For 22 years at Tchaikapharma I have learned a lot – the key to success is to climb all the “steps” consistently – says Mgr. Pharm. Silvia Patrikova, member of the Board of Directors of Tchaikapharma   Ms. Patrikova, how would you introduce yourself in three sentences?   I graduated in Pharmacy at MU-Sofia and […]

  • July 3, 2023

    “Tchaikapharma is the first Bulgarian organization to support the Stand Up To Cancer initiative. What was your motivation and why now?   SU2C is massively supported by the entertainment industry and leading global media with a very critical and self-critical view on the funding and implementation of scientific programs and research. With one important exception […]